The plasma levels of TL1A were obviously higher in newly diagnosed SLE patients than in a control group [49], and the frequency of duplication of the DR3 gene is increased in RA patients compared to controls [50]. The gene discussed is TNFRSF25; the disease is rheumatoid arthritis.